Datamatics Global Services (Datamatics) has entered into a strategic partnership with Alkermes, a global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.

The partnership is focused on enhancing Alkermes' patient support services for people prescribed Alkermes medicines.

As part of this collaboration, which began with a competitive procurement process during which Datamatics was selected; Datamatics has deployed a remote patient coordinator service staffed with a team of individuals with healthcare experience to support patients in accessing their medicines and reminding them of their appointments.

Datamatics is also helping modernize existing systems and processes to enable the Alkermes' Patient Access Services team to enhance the customer experience.

Powered by Capital Market - Live News

Datamatics Global Services announced that the Board of Directors of the Company at its meeting held on 28 April 2023, inter alia, have recommended the special dividend of Rs 1.25 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Datamatics Global Services announced that the Board of Directors of the Company at its meeting held on 28 April 2023, inter alia, have recommended the final dividend of Rs 3.75 per equity Share (i.e. 75%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Datamatics Global Services rose 30.91% to Rs 59.72 crore in the quarter ended March 2023 as against Rs 45.62 crore during the previous quarter ended March 2022. Sales rose 32.87% to Rs 416.28 crore in the quarter ended March 2023 as against Rs 313.30 crore during the previous quarter ended March 2022.

For the full year,net profit rose 19.98% to Rs 188.95 crore in the year ended March 2023 as against Rs 157.48 crore during the previous year ended March 2022. Sales rose 21.49% to Rs 1459.19 crore in the year ended March 2023 as against Rs 1201.05 crore during the previous year ended March 2022.

Powered by Capital Market - Live News